Insider Buying: Lacey John III Acquires 48,917 PVCT Shares
Lacey John III bought 48,917 shares of PVCT on June 30, 2026.
Key Points
- Lacey John III bought 48,917 shares of PVCT on June 30, 2026, with shares trading at $0.07 on Wednesday.
- PVCT's stock has seen various insider buying activities, with peers like Atlas Wealth LLC opening new positions.
- Other insiders, including President Dominic Rodrigues and CEO Edward Pershing, also made transactions in June 2026.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Lacey John III recently bought 48,917 shares of PVCT on June 30, 2026. This insider transaction did not involve a pre-planned trading plan, indicating a direct purchase. As of Wednesday, PVCT shares were trading at $0.07.
Insider Buying and Selling at Provectus Biopharmaceuticals, Inc.
The recent activity at PVCT saw several insiders purchasing shares. On June 30, 2026, Dominic Rodrigues, the President, acquired 45,860 shares. Webster Bailey also bought 48,917 shares on the same day. Earlier in the month, CEO Edward Pershing was active, buying 5,242 shares on May 28 and 9,436 shares on June 5, while also selling the same amount on June 5.
Other Institutional Activity in PVCT
Among PVCT's institutional investors, Atlas Wealth LLC opened a new position with 19,620 shares valued at approximately $999. Home Federal Bank of Tennessee maintained its holdings at 100,000 shares worth about $5,100. Wealth Preservation Advisors, LLC also held steady with 52,600 shares valued at around $2,677. Financial Symmetry Inc kept its position unchanged with 10,191 shares valued at $581.
Bottom Line
Insider buying at PVCT, including significant purchases by Lacey John III and other key figures, highlights ongoing interest in the company. Institutional investors like Atlas Wealth LLC are also making moves, further drawing attention to PVCT's stock activities. As always, remember that insider trades are disclosed after the fact and may not reflect current positions.
Get Provectus Biopharmaceuticals, Inc. alerts
New 13F filings, insider trades, and analyst moves on $PVCT, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.